亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Treating metabolic dysfunction‐associated steatohepatitis: The fat‐trimming FGF21 approach

脂毒性 脂肪变性 FGF21型 医学 脂肪性肝炎 脂质代谢 非酒精性脂肪肝 胰岛素抵抗 脂肪肝 脂解 脂滴 内科学 内分泌学 生物信息学 糖尿病 脂肪组织 生物 疾病 成纤维细胞生长因子 受体
作者
Xiaokun Li,Zhiheng Rao,Wenhao Hu,Weiqin Lu,Yongde Luo
出处
期刊:Obesity Reviews [Wiley]
卷期号:26 (3): e13861-e13861 被引量:5
标识
DOI:10.1111/obr.13861
摘要

Metabolic dysfunction-associated steatohepatitis (MASH) is a condition characterized by hepatosteatosis, inflammation, and tissue damage, with steatosis as the initial stage, which involves chronic, excess deposition of lipids in hepatic lipid droplets. Despite the growing prevalence and serious risks it poses, including liver decompensation, the need for transplantation, and increased patient mortality, MASH currently faces no approved pharmacotherapy. Several promising treatment candidates have emerged from recent clinical trials, including analogs of FGF21 and agonists of the associated FGFR1-KLB complex. These agents were well-tolerated in trials and have demonstrated significant improvements in both histological and biochemical markers of liver fat content, inflammation, injury, and fibrosis in patients with MASH. Endocrine FGF21 plays a vital role in maintaining homeostasis of lipid, glucose, and energy metabolism. It achieves this through pathways that target lipids or lipid droplets in adipocytes and hepatocytes. Mechanistically, pharmacological FGF21 acts as a potent catabolic factor to promote lipid or lipid droplet lipolysis, fatty acid oxidation, mitochondrial catabolic flux, and heat-dissipating energy expenditure, leading to effective clearance of hepatic and systemic gluco-lipotoxicity and inflammatory stress, thereby preventing obesity, diabetes, and MASH pathologies. In this review, we aim to provide an update on the outcomes of clinical trials for several FGF21 mimetics. We compare these outcomes with preclinical studies and offer a lipid-centric perspective on the mechanisms underlying the clinical benefits of these agents for MASH.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
donk666完成签到,获得积分10
1秒前
华无剑的应助被hyman采纳,获得10
3秒前
彭于晏的应助被小祝没吃饱采纳,获得10
4秒前
Bruce完成签到 ,获得积分10
9秒前
芫荽子完成签到,获得积分20
11秒前
奔跑的应助被纯情的阁采纳,获得10
13秒前
Maestro_S的应助被纯情的阁采纳,获得10
13秒前
Maestro_S的应助被纯情的阁采纳,获得10
13秒前
奔跑的应助被纯情的阁采纳,获得10
13秒前
Maestro_S的应助被纯情的阁采纳,获得10
13秒前
Maestro_S的应助被纯情的阁采纳,获得30
13秒前
Maestro_S的应助被纯情的阁采纳,获得10
13秒前
Maestro_S的应助被纯情的阁采纳,获得10
13秒前
14秒前
跳跃的咖啡豆完成签到,获得积分10
16秒前
null的应助被科研通管家采纳,获得10
17秒前
今后的应助被科研通管家采纳,获得10
18秒前
18秒前
n01W97的应助被科研通管家采纳,获得20
18秒前
18秒前
18秒前
null的应助被科研通管家采纳,获得10
18秒前
18秒前
20秒前
懦弱的棉花糖完成签到,获得积分10
50秒前
淡淡的向雁完成签到,获得积分10
55秒前
55秒前
1分钟前
niein完成签到,获得积分20
1分钟前
复杂的醉山完成签到,获得积分10
1分钟前
1分钟前
Xrey完成签到 ,获得积分10
1分钟前
1分钟前
1分钟前
1分钟前
充电宝的应助被niein采纳,获得30
1分钟前
1分钟前
1分钟前
安静白柏完成签到,获得积分10
1分钟前
情怀的应助被麦辣基米堡采纳,获得10
1分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1500
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
What Else Can I Tell You?: A Pragmatic Study of English Rhetorical Questions as Discursive and Argumentative Acts 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8158726
求助须知:如何正确求助?哪些是违规求助? 9554476
关于积分的说明 21719198
捐赠科研通 7748281
什么是DOI,文献DOI怎么找? 3427072
关于科研通互助平台的介绍 2551964
邀请新用户注册赠送积分活动 2471308